Everolimus for Compassionate Use in Multiple Basal Cell Carcinomas

Table 1

Blood chemistry and haematology parameters assessed at baseline and end of treatment with everolimus.

	Patient 1		Patient 2		Patient 3		Patient 4
	Baseline	End of treatment	Baseline	End of treatment	Baseline	End of treatment	Baseline	End of treatment
Creatinine (mg dL^−1)	1.00	1.20	0.90	0.80	0.84	0.81	1.13	0.90
Triglycerides (mg dL^−1)	153	198	50	91	82	118	100	117
Cholesterol (mg dL^−1)	195	195	167	207	138	175	195	203
Haemoglobin (g dL^−1)	13.0	10.0	12.0	12.5	10.0	9.2	14.5	13.6
Haematocrit (%)	38.0	30.0	37.0	37.1	32.0	27.0	41.7	41.7
Platelets (×10^3 µL^−1)	261	238	280	360	151	238	269	245